PRESIDENT AND CHIEF EXECUTIVE OFFICER Age: 61 Director Since: 2024 Committees: None Mr. Blaser became our President, CEO, and a director in May 2024. Mr. Blaser previously served as Executive Vice President, Diagnostic Products of Abbott Laboratories, a global medical device company, from 2012 to June 2019, where he oversaw the company s global diagnostics organization, including its core laboratory, point of care, rapid diagnostics and molecular diagnostics businesses. Prior to that role, Mr. Blaser served in various strategic, operational and diagnostic roles at Abbott Laboratories, since joining the company in 2004. Previously, he served in various leadership positions in operations, finance and engineering at the Ortho Clinical Diagnostics ( Ortho ) division of Johnson & Johnson, Eastman Kodak and General Motors. Mr. Blaser served on the board of directors of Quanterix Corp., a life sciences company, from 2023 to 2024. He also previously served on the board of directors of Meridian Bioscience Inc. and as senior advisor to McKinsey & Company. He currently serves as a member of the Board of Trustees of the University of Dayton and as the chair of the AdvaMedDx Division Board of Directors. Mr. Blaser received his M.B.A. with a Finance concentration from the Rochester Institute of Technology and his B.Sc. in Mechanical Engineering Technology from the University of Dayton. Mr. Blaser brings extensive diagnostics and senior leadership experience through his 15 years at Abbott Laboratories and his tenure at Ortho. He also has substantial governance experience through his service on the boards of directors of other public companies. Other Current Public Company Directorships: None Prior Public Company Directorships Within the Past 5 Years: Quanterix Corp. until 2024